Masonicare Becomes First Multi-Location Provider to Achieve Multiple Purple Flag Reaccreditations, Adding Ashlar Village

Masonicare at Ashlar Village senior living community became the third Purple Flag™ community nationwide to celebrate its reaccreditation in dementia care. With this flag-raising, Masonicare becomes the first multi-location provider to achieve multiple reaccreditations. Masonicare at Mystic also achieved reaccreditation earlier this month.

Masonicare at Ashlar Village earned Purple Flag accreditation in 2021, which helped establish it as a leader in dementia care. Purple Flag has seen tremendous growth nationwide since then, with 32 accredited communities now flying the Purple Flag.

“With Masonicare’s intentional mission to reaccredit multiple communities, it shows these accreditations accomplish our goal of cutting-edge memory care support,” said Christopher Carter, Purple Flag CEO and President, CALA. “Masonicare at Ashlar Village’s Reaccreditation confirms the community’s steadfast and unwavering goal to create the best quality of life for their residents.”

Purple Flag for Dementia Care is an accreditation program with established standards for assessing an organization’s ability to provide collaborative care for persons living with dementia in a safe, functional and respectful environment. The program was initially developed through a joint effort between the Institute for Senior Living Education (ISLE) and the Connecticut Assisted Living Association (CALA) to ensure memory care residents with Alzheimer’s and other forms of dementia receive the highest quality care and enhanced quality of life. Since its establishment, Purple Flag has grown to evaluate all levels of senior care and provider environments.

As part of the reaccreditation process, Masonicare at Ashlar Village had to demonstrate compliance and resourcefulness to the 10 Best Practice Program Standards and trainings outlined by Purple Flag for services provided to individuals with Alzheimer’s and other forms of dementia. Masonicare at Ashlar Village is the third among the Purple Flag communities to have met the standards to elevate care quality for all residents a second time. Other communities plan to follow with more reaccreditations.

“This achievement confirms our belief in the Purple Flag organization,” said Rachael Laudano, Executive Director Assisted Living, Masonicare at Ashlar Village. “It’s a testament to the quality of life and individualized care our Masonicare at Ashlar Village residents continue to receive every day. The systematic training our staff has acquired allows us to remain at the forefront of assisted living communities offering dementia care.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”